Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C

Indian J Gastroenterol. 2004 Jan-Feb;23(1):28-9.

Abstract

We report a 47-year-old woman who developed features of rheumatoid arthritis 20 weeks after initiation of treatment with pegylated interferon and ribavirin for chronic hepatitis C. She continued to have symptoms six months after discontinuation of the drugs which she received for 24 weeks with rival clearance.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / adverse effects*
  • Arthritis, Rheumatoid / chemically induced*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Middle Aged
  • Polyethylene Glycols / adverse effects*
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a